About Levin Formulations
The company has 20 employees. Levin Formulations offers products and services including LEVITOR Series and GILFORMIN Variants.
- Employees 20
- SectorsHealthcare
- Email••••••••
- Legal Name Levin Formulations Pvt. Ltd
- Date of Incorporation 14 Jun, 2019
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹2.36 Cr
FY 2025 · -13% YoY
- Net Loss-₹67.9 Lakh
FY 2025 · -29% margin
- EBITDA-₹44.1 Lakh
FY 2025 · -19% margin
- Employee Count20
Associated legal entities of Levin Formulations
Levin Formulations operates through Levin Formulations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Levin Formulations Private Limited CIN U24100TG2019PTC133420 | Active | 14 Jun 2019 | Hyderabad, Telangana | ₹2.4 Cr | 20 | 3 | View details |
Products & Services of Levin Formulations
Levin Formulations offers a comprehensive portfolio of products and services, including LEVITOR Series and GILFORMIN Variants.
The LEVITOR series is manufactured for chronic conditions and marketed as part of pharmaceutical offerings
GILFORMIN variants are produced for managing chronic health issues and distributed in the healthcare sector
Board of directors of Levin Formulations Private Limited (Levin Formulations)
Levin Formulations Private Limited is the primary company behind Levin Formulations. The board of Levin Formulations Private Limited currently have 3 directors; the longest-serving is Kunchala Srinivasarao, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kunchala Srinivasarao DIN 06865092 | Director | 14 Jun 2019 | 7 yrs 3 mo | Levin Formulations Private Limited |
| Anasuya Kunchala DIN 07052104 | Director | 14 Jun 2019 | 7 yrs 3 mo | Levin Formulations Private Limited |
| Praveen Kumar Perumandla DIN 08482747 | Director | 14 Jun 2019 | 7 yrs 3 mo | Levin Formulations Private Limited |
Financials of Levin Formulations
Figures of Levin Formulations Private Limited, the primary company behind Levin Formulations, for FY 2025. Revenue was ₹2.36 Cr (-13% year on year). Net loss was -₹67.9 Lakh (-29% margin). EBITDA was -₹44.1 Lakh (-19% margin). Revenue has grown at a compounded annual rate of -5% over three years and +38% over five years.
- ₹2.36 CrRevenue · FY 2025 · -13% YoY
- -₹67.9 LakhNet loss · -29% margin
- -₹44.1 LakhEBITDA · -19% margin
- ₹10 LakhPaid-up capital
- 20Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Levin Formulations Private Limited are on its company page.
Detailed financial statements for Levin Formulations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Levin Formulations
10 companies that operate in the same segment as Levin Formulations (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Levin Formulations
Levin Formulations has 20 employees.
The primary company behind Levin Formulations, Levin Formulations Private Limited, reported revenue of ₹2.36 Cr for FY 2025, down 13% year on year.
Levin Formulations Pvt. Ltd. is recognized as a pharmaceuticals organization that concentrates on the manufacturing and marketing of products for chronic conditions. It was established in 2013 and converted to a private limited entity in 2019, with a vision centered on providing quality healthcare through essential and difficult-to-make medicines. Consistent growth is noted in the industry, emphasizing sustainability and a focus on humanitys health needs. Products such as LEVITOR and GILFORMIN are developed to address ongoing health challenges.
Levin Formulations offers LEVITOR Series and GILFORMIN Variants.
Levin Formulations operates through Levin Formulations Private Limited.
The legal entities of Levin Formulations currently have 3 directors, including Kunchala Srinivasarao, Anasuya Kunchala, Praveen Kumar Perumandla.